血管活性介质,vasoactive mediator
1)vasoactive mediator血管活性介质
1.Clinical observation on effects of Shengmai injection(生脉注射液) on plasmavasoactive mediators in patients with systemic inflammatory response syndrome;生脉注射液对全身炎症反应综合征患者血浆血管活性介质影响的临床观察
2)Vasoactive substance血管活性物质
1.Study on the role of vasoactive substances in the pathogenesis of hypertension in patients with sleep apnea syndrome;血管活性物质在睡眠呼吸暂停综合征合并高血压中作用的研究
2.Effect of sleep-apnea syndrome on vasoactive substances;睡眠呼吸暂停低通气综合征患者血管活性物质的变化
3.The effects of nCPAP on blood pressure and vasoactive substances in patients with SAS;nCPAP治疗SAS的效果及对血压和血管活性物质的影响
英文短句/例句
1.Blood vessel active material and cardiovascular disease patient"s relevant analysis血管活性物质与心血管疾病患者的相关性分析
2.The Role of Vaso active Substance in the Patients with Pregnancy Induced Hypertension血管活性物质在妊高征发病中的作用
3.Study on the Relationship of Vasoactive Peptodes Such as Adrenomedullin to the Risk Stratification in Essential Hypertension;肾上腺髓质素等血管活性物质与原发性高血压危险性分层的关系
4.The Comparisons of Vascular Function in Resistance Vessels of Different Age Rats;不同年龄大鼠阻力血管对不同血管活性物质反应性比较
5.The Role of Reactive Oxygen Species in Cardiohypertrophy Which Induced by the Vascular-systolic Substances;氧活性产物介导缩血管活性物质促进心肌细胞分泌内皮素
6.The changes of the vasoactive factors in normal pregnancy and pregnancy induced hypertension;血管活性物质在正常妊娠及妊高征中的变化
7.The Effect of Continuous Blood Purification on Plasma Vasoactive Substances in Piglets with Endotoxic Shock;连续血液净化对内毒素休克幼猪血浆血管活性物质水平的影响
8.Study on Vaso-active Substance in Serum of Essential Hypertensive by the Treatment of Acupuncturing Renying Point针刺人迎穴对高血压患者血清中血管活性物质影响的研究
9.Effects of Age and Gender on the Circadian Rhythm of Blood Pressure and Endothelial Vasoactive Substances;年龄和性别对血压及内皮源性血管活性物质近日节律的影响
10.Survey of Studies on the Involvement of Vaso-active Sub stances in Acu-moxibustion Treatment of Cardio-cerebrovascular Diseases血管活性物质在针灸治疗心脑血管疾病中作用的研究概况
11.The Influence and Clinical Significance of SINITANG on Experimental Renal Hypertension Models of Rats;四逆汤对大鼠肾性高血压部分血管活性物质的影响及其临床意义
12.The Experimental Study on Part of Vasoactive Substances Following Acute Pulmonary Thromboembolism in Dogs;犬急性肺血栓栓塞模型部分血管活性物质的实验研究
13.Changes in the Plasma Levels of Some Vasoactive Substances and the Pathogenetic Significances in Descendants of Parents with Essential Hypertension;原发性高血压前期血管活性物质水平变化及其意义研究
14.The Study on the Relationship of Some Vasoactive Substances to the Heredity of Essential Hypertension;NO等血管活性物质与原发性高血压遗传关系的研究
15.Effect of Shenluotong on RAS, ET-1 and TXB_2 in Obstructive Nephropathy Rats肾络通对肾间质纤维化实验动物大鼠肾组织血管活性物质的作用
16.Circadian Rhythms of Vaso-active Substances and Their Effects on Blood Pressure;血管活性物质的近日节律现象及其对血压的影响
17.Influence of Toufengyu Dropping Pill on vasoactive substances in migraine rat头风愈滴丸对偏头痛大鼠血中血管活性物质的影响
18.Influence of vasoactive substances on blood pressure of children undergoing laparoscopic operation小儿腹腔手术中血管活性物质的变化对血压的影响
相关短句/例句
Vasoactive substance血管活性物质
1.Study on the role of vasoactive substances in the pathogenesis of hypertension in patients with sleep apnea syndrome;血管活性物质在睡眠呼吸暂停综合征合并高血压中作用的研究
2.Effect of sleep-apnea syndrome on vasoactive substances;睡眠呼吸暂停低通气综合征患者血管活性物质的变化
3.The effects of nCPAP on blood pressure and vasoactive substances in patients with SAS;nCPAP治疗SAS的效果及对血压和血管活性物质的影响
3)Vasoactive substances血管活性物质
1.Effects of soy oligosaccharides and peptides on vasoactive substances and hemorheology in hyperlipidemia rats;大豆低聚糖和低聚肽对高脂血症大鼠血管活性物质和血液流变学的影响
2.Changes of vasoactive substances originated endothelium on patients with unstable angina pectoris treated by low dose of urokinase;不稳定型心绞痛患者应用小剂量尿激酶前后内皮源性血管活性物质的变化(英文)
3.Objective To observe the influence of preventive treatment by regulating the function of liver and kidney and removing sputum and blood stasis therapy (RR-Therapy) on the development of SHR hypertension and several vasoactive substances.目的 探讨调肝肾、祛痰瘀治法方药提前干预对自发性高血压大鼠(SHR)的高血压发展以及对多种血管活性物质的作用。
4)vaso-active substance血管活性物质
1.Vaso-active substances including nitric oxide(NO) and endothelin(ET) were measured.方法 :选择无心血管疾病的SAS患者和正常对照组各 30例进行多导睡眠图 (PSG)、2 4h动态血压 (ABPM )及血管活性物质一氧化氮 (NO)和内皮素 (ET)的监测。
2.The methods of treating EH with Chinese medicine are mainly from following links:to change hemodynamics and hemorheology mechanisms;to affect RAS;to adjustvaso-active substance;to control the function of cell membranes\" calcium channel and to resist IR.中医药治疗高血压的途径主要从一下几个环节入手:改变血流动力学和血液流变学机制、对肾素—血管紧张素系统的影响、调节血管活性物质、调控细胞膜钙通道的机能以及抑制胰岛素抵抗等。
5)vasoactive factors血管活性物质
6)Vasoconstrictor[英][,v?s?uk?n"strikt?][美][,v?sok?n"str?kt?]缩血管活性物质
1.Object To find the role of ROS in increased paracrine of hypertrophic cardiomyocytes induced by the vasoconstrictors including ET-1 ,AngⅡ.目的:探讨氧活性产物(reactive oxygen species,ROS)在血管紧张素Ⅱ(AngⅡ),内皮素-1(ET-1)等缩血管活性物质在致心肌细胞肥大时同时促进心肌细胞分泌内皮素中所起的作用。
延伸阅读
肠血管活性多肽肠血管活性多肽又称"血管活性肠肽"。 VIP最初从猪肠中分离获得，现已能人工合成。它的突出作用为强烈的血管扩张。可有正性心肌肌力作用，但可引起血压下降。在胃肠道其作用很广泛，可抑制胃酸、胃蛋白酶分泌，使胃肌松弛；激活肠粘膜的腺苷酸环化酶而促进肠液分泌及肠道收缩；促进胰分泌HCOs-及水；还能加强胰岛素及高血糖素分泌，促进糖原及脂肪分解。但目前对它的本质的了解不清楚，有待研究。
